NDC 0270-7017-20 - IOMERVU
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0270-7017
- Requested NDC
- 0270-7017-20
- Package NDCs from labels
- 0270-7017-20, 0270-7017-21, 0270-7017-24, 0270-7017-25
- Manufacturer
- BRACCO DIAGNOSTICS INC | BIPSO GmbH | SPIN S.p.A. | BioChem Labor für biologishe und chemische Analytik GmbH
- Effective date
- 2026-02-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Iomeprol Injection | BRACCO DIAGNOSTICS INC | BIPSO GmbH | SPIN S.p.A. | BioChem Labor für biologishe und chemische Analytik GmbH | 2026-02-05 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0270-7017-20 | IOMERVU | 50 mL in 1 VIAL, GLASS | INJECTION, SOLUTION | 50 | 4 | |
| 0270-7017-20 | IOMERVU | 10 in 1 CASE | INJECTION, SOLUTION | 10 | 4 | |
| 0270-7017-21 | IOMERVU | 100 mL in 1 BOTTLE, GLASS | INJECTION, SOLUTION | 100 | 4 | |
| 0270-7017-21 | IOMERVU | 10 in 1 CASE | INJECTION, SOLUTION | 10 | 4 | |
| 0270-7017-24 | IOMERVU | 10 in 1 CASE | INJECTION, SOLUTION | 10 | 4 | |
| 0270-7017-24 | IOMERVU | 150 mL in 1 BOTTLE, GLASS | INJECTION, SOLUTION | 150 | 4 | |
| 0270-7017-25 | IOMERVU | 10 in 1 CASE | INJECTION, SOLUTION | 10 | 4 | |
| 0270-7017-25 | IOMERVU | 200 mL in 1 BOTTLE, GLASS | INJECTION, SOLUTION | 200 | 4 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| THAM | TROMETHAMINE | Hospira, Inc. | 4af52118-c12b-4ad5-30bb-959848357e8a | 2026-05-27 | Warnings, Adverse reactions | 023C2WHX2V |
| IOMERVU | IOMEPROL INJECTION | BRACCO DIAGNOSTICS INC | cb2e0e00-7c93-0fb4-89a5-861641662a5a | 2026-02-05 | Boxed warning, Warnings, Adverse reactions | NDA216016 0270-7017-24 0270-7017-25 0270-7018-28 0270-7018-29 0270-7017-21 0270-7017-20 0270-7018-26 0270-7018-27 0270-7017 0270-7018 00270701720 50c571d8-759c-b711-b696-41c07a6ad82a cb2e0e00-7c93-0fb4-89a5-861641662a5a 17E17JBP8L |
| Tromethamine | TROMETHAMINE | MILLA PHARMACEUTICALS INC. | 082b1104-502b-47af-95bf-0dbf2422990e | 2026-01-07 | Warnings, Adverse reactions | 023C2WHX2V |
| Iomeron | IOMEPROL INJECTION | BRACCO DIAGNOSTICS INC | 4b31d479-fd1c-5ed7-5bdf-dfd34fe08d98 | 2025-11-19 | 17E17JBP8L | |
| Iomeron | IOMEPROL INJECTION | BIPSO GmbH | 30a993a8-9afb-42c2-a4b2-72a6b361d43c | 2025-11-19 | 17E17JBP8L | |
| TROMETHAMINE | TROMETHAMINE | B. Braun Medical Inc. | 57db5686-7f7f-4999-87e3-e1cbbda4a98d | 2024-12-23 | Warnings, Adverse reactions | 023C2WHX2V |
| AnubisMed | SPF 50 BROAD SPECTRUM PROTECTION FLUID EMULSION | ANUBIS COSMETICS SL | e99d92c4-8768-9c0a-e053-2a95a90a609e | 2023-09-05 | Warnings | 023C2WHX2V |
| Anubis Barcelona Protective Line | ETHYLHEXYL METHOXYCINNAMATE, BUTYL METHOXYDIBENZOYLMETHANE, ETHYLHEXYL SALICYLATE, OCTOCRYLENE | ANUBIS COSMETICS SL | ec83846f-11c0-8f59-e053-2995a90ab9d2 | 2023-09-01 | Warnings | 023C2WHX2V |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.